ANTI-PD-1 ANTIBODIES AND USES THEREOF - Patent 3810651

(19)

(11)

EP 3 810 651 A1

(12)

(43)	Date of publication:
	28.04.2021 Bulletin 2021/17

(21)	Application number: 19735113.3

(22)	Date of filing: 18.06.2019

(51)

International Patent Classification (IPC):

C07K 16/28^(2006.01)

A61P 35/00^(2006.01)

(86)	International application number:
	PCT/US2019/037750

(87)	International publication number:
	WO 2019/246110 (26.12.2019 Gazette 2019/52)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

20.06.2018 US 201862687673 P
06.11.2018 US 201862756319 P

(71)	Applicants:
	Incyte Corporation Wilmington, DE 19803 (US) MacroGenics, Inc. Rockville, MD 20850 (US)

(72)	Inventors:
	CORNFELD, Mark Wilmington, Delaware 19803 (US) PANDYA, Naimish BHARAT Rockville, Maryland 20850 (US) WIGGINTON, Jon MARC Rockville, Maryland 20850 (US) LA MOTTE-MOHS, Ross Rockville, Maryland 20850 (US) SUMROW, Bradley JAMES Rockville, Maryland 20850 (US)

(74)	Representative: Chapman, Desmond Mark
	Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA London WC1B 5HA (GB)

(54)	ANTI-PD-1 ANTIBODIES AND USES THEREOF